Alexion Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 94 Posts
1 2 3 ... 6
5 Big Drug/Biotech Stocks Set To Trump Q4 Earnings Estimates
Article By: Zacks Investment Research Wednesday, January 22, 2020 4:00 PM EST
A highlight of five big drug/biotech companies, which are expected to deliver positive earnings surprise in their upcoming quarterly earnings announcements.
In this article: AZN, MRK, ALXN, AMGN, ABBV
Read
Alexion To Acquire Achillion Pharma For $930M
Article By: Benzinga Wednesday, October 16, 2019 9:06 AM EST
Alexion Pharma will buy Achillion Pharma for the initial value of $930 million, or $6.30 per share in cash plus added contingent considerations for a total potential value of $8.30 per share.
In this article: ALXN, ACHN
Read
3 Big Drug/Biotech Stocks Set To Beat Q3 Earnings Estimates
Article By: Zacks Investment Research Saturday, October 12, 2019 10:00 AM EST
Overall, relatively newer drugs have been driving the top line of most of the big shots backed by higher demand - a trend we expect to have benefited third-quarter sales.
In this article: LLY, ALXN, AMGN Also: JNJ
Read
Biotech (Top 30 Weights) 2019 Earnings Estimates Up 8.58% In Last 2 Months
Article By: T.J. Hayes Monday, September 9, 2019 7:36 PM EST
The cumulative earnings power of these 30 stocks was revised UP by 8.58% in the past 60 days.
In this article: ALNY, ALXN, BMRN, CBPO, ILMN, INCY, JAZZ, REGN, SGEN, AMGN, BIIB, CELG, EXEL, GILD, HZNP, MYL, NBIX, TECH, VRTX, AMRN, SAGE, GWPH, SRPT, BLUE, NVCR, IONS, BGNE, PRAH, SYNH, IBB
Read
A Glass Half Full Or Glass Half Empty – The Fate Of The Stock Market
Article By: Michael J. Kramer Tuesday, September 3, 2019 4:42 PM EST
The three-ring circus continues with the S&P 500 on September 3 refilling a gap from last week.
In this article: GE, ALXN, AMZN, MSFT, SPX, SQ
Read
Healthcare And Biotechs Feel The Heat As The Market At New Highs
Article By: Tarun Chandra, CFA Wednesday, May 1, 2019 12:14 PM EST
The stock market has continued to edge higher and the two major indexes, the Nasdaq (QQQ) and S&P 500 (SPY​), touched the all-time high milestone last week.
In this article: ACAD, ALXN, ARRY, AMRN, ARWR, AXSM, ASND
Read
5 Rallying Stocks For A Strong Q4
Article By: TipRanks Thursday, October 4, 2018 12:14 PM EST
All these stocks are up over 10% or more in the last month.
In this article: CXO, CI, ALXN, BA, NTES
Read
Biotech ETFs In Focus On String Of Q2 Earnings Beats
Article By: Zacks Investment Research Sunday, August 12, 2018 4:27 PM EST
The biotech sector has been performing remarkably well driven by a wave of mergers and acquisitions, new tax legislation, and a positive regulatory backdrop. Strong Q2 earnings results have added to the strength as biotech giants topped estimates.
In this article: IBB, AMGN, GILD, BBH, FBT, ALXN, BIIB
Read
Scan And Plan For Today’s Range And The Future Breakout
Video By: TheoTrade Thursday, May 24, 2018 5:01 PM EST
Stocks sold off this morning on the news that President Trump canceled the meeting with North Korea. However, stocks recouped most of the loses by the close. In tonight's video newsletter we look at stocks that are break out candidates.
In this video: ALXN, USB, AMT, COO, DGX, HRB, CMG, PM
Watch
2018 Biotech Sector Watch On Earnings: ABBV, ALXN, BMY
Article By: Rod Raynovich Thursday, April 26, 2018 6:00 PM EST
Abbvie (ABBV) is back on track. Alexion (ALXN) stock soared 14.6%. Bristol Myers-Squibb (BMY) raised its full year earnings forecast.
In this article: BMY, ALXN, ABBV Also: IBB, CELG, XBI, EDIT, CRSP
Read
Goldman Sachs: These 5 Stocks Can Break Higher
Article By: TipRanks Sunday, April 22, 2018 12:29 PM EST
With the market in gridlock, Goldman Sachs has identified 14 stocks that seem to offer big upside potential.
In this article: NBL, NFX, ALXN, INCY, AVGO
Read
Alexion To Acquire Sweden's Wilson Therapeutics For $855M In Cash
Article By: The Fly Wednesday, April 11, 2018 8:05 AM EST
Alexion Pharmaceuticals and Wilson Therapeutics AB announced that Alexion has made a recommended public cash offer to the shareholders in Wilson Therapeutics to acquire all outstanding shares in Wilson Therapeutics by way of a tender offer.
In this article: ALXN
Read
Alexion Jumps After Blood Disorder Drug Succeeds In Head-To-Head Trial
Article By: The Fly Thursday, March 15, 2018 8:36 AM EST
Shares of Alexion jumped in pre-market trading after the company said its rare blood disorder drug was successful in a late-stage study.
In this article: ALXN
Read
5 Top Stocks To Survive A Trade War
Article By: TipRanks Sunday, March 4, 2018 5:58 PM EST
President Trump has just announced that the US is about to impose 25% tariffs on steel imports and 10% on aluminium imports. But for Fundstrat founder and head of research Tom Lee the market is overreacting.
In this article: BA, PXD, RTN, ALXN, VRTX
Read
EC 2018 Outlook – Biotech Bonanza: Biotech Stocks To Keep Shining
Article By: Tarun Chandra, CFA Sunday, December 17, 2017 11:58 AM EST
Biotech is not an easy sector to invest in - 95 percent of the oncology drugs that enter clinical trials fail. But that is no reason to ignore biotechs. We believe biotech stocks in 2018 will deliver double-digit returns of around 20%.
In this article: ALNY, ALXN, ABEO Also: ASH, ARNA, AMGN, BIIB, ANAB, SPPI, ZGNX, NKTR, EXAS, SAGE, HALO, SGMO, DVAX, INSM, XBI, JUNO, ESPR, LOXO, RVNC, LABD, LABU, BPMC, MRTX, NVS, CLLS, BLUE, BMY, INCY, CELG, GILD, VRTX, REGN
Read
Goldman Thinks It’s Time You ‘Sharpe’n Up
Article By: The Heisenberg Report Saturday, December 16, 2017 3:30 PM EST
You damn sure can’t try to be a hero by betting against this self-fulfilling prophecy because that’s a one-way ticket to underperformance in a world where change has become impossible.
In this article: RRC, TAP, WDC, XRX, ALXN, DISH
Read
1 to 16 of 94 Posts
1 2 3 ... 6